Cash Flow Statement (2010. 7. 1. Spin off)

Home > investors > Hanmi Pharm > Financial Reports

Unit : 1 million won
Particulars 2011. 3Q 2010
Cash flows from operating activities 40,162 3,725
Cash flows from investing activities -12,541 -25,509
Cash flows from financing activities -18,543 20,463
Net increase (decrease) in cash and cash equivalents 9,078 -1,321
Cash and cash equivalents at beginning of period 13,010 7,583
Effect of Exchange Rate Changes on Foreign Current Cash and Cash Equivalents 6 0
Cash and cash equivalents at end of period 22,095 6,262